Showing results (1541-1550 of 2,173) with videos related to

Sort By:
Pageof 218
Langmuir : the ACS Journal of Surfaces and Colloids|August 14, 2010
A comparison of covalent immobilization and physical adsorption of a cellulase enzyme mixtureS L Hirsh, M M M Bilek, N J Nosworthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2010
The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trialsPaul Wheatley-Price, Aurélie Le Maître, Keyue Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
Mastocytosis-derived extracellular vesicles exhibit a mast cell signature, transfer KIT to stellate cells, and promote their activationDo-Kyun Kim, Young-Eun Cho, Hirsh D Komarow, et al.
Journal of Cardiothoracic and Vascular Anesthesia|February 10, 2007
The role of endogenous kallikrein inhibition in perioperative transfusion and adverse outcome in cardiac surgical patientsCatherine M N O'Malley, Robert J Frumento, Ian J Mackie, et al.
Journal of Clinical Gastroenterology|June 1, 2022
Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysisHirsh D Trivedi, Emily W Lopes, Jeremy Glissen Brown, et al.
British Journal of Haematology|January 1, 1985
Placental transport of low molecular weight heparin in the pregnant sheepM Andrew, B Boneu, J Cade, et al.
The Journal of Allergy and Clinical Immunology. Global|May 31, 2024
Autoantibodies to type I interferons in patients with systemic mastocytosisVivian Cao, Serena J Lee, Yun Bai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Randomized, double-blind, phase II trial comparing gemcitabine-cisplatin plus the LTB4 antagonist LY293111 versus gemcitabine-cisplatin plus placebo in first-line non-small-cell lung cancerPasi A Jänne, Luis Paz-Ares, Yun Oh, et al.
Pageof 218